Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Menter

Showing results (101-110 of 298) with videos related to

Pageof 30
Sort By:
Expert Opinion on Biological Therapy|March 12, 2010
The use of ustekinumab in autoimmune diseaseCaitriona Ryan, Breck Thrash, Richard B Warren, et al.
Proceedings (Baylor University. Medical Center)|December 8, 2005
Meandering linear pruritic lesionJennifer Clay Cather, J Christian Cather, M Alan Menter
Dermatology and Therapy|March 31, 2016
Erratum to: A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque PsoriasisMolly Campa, Bobbak Mansouri, Richard B Warren, et al.
International Journal of Dermatology|March 28, 2017
Prevalence of psoriasis in Brazil - a geographical surveyRicardo Romiti, Marcelo Amone, Alan Menter, et al.
Journal of Drugs in Dermatology : JDD|November 9, 2012
Impact of clobetasol propionate 0.05% spray on health-related quality of life in patients with plaque psoriasisM Alan Menter, Scott W Caveney, Ronald W Gottschalk
Cutis|March 2, 2021
Erythema Ab Igne and Malignant Transformation to Squamous Cell CarcinomaElizabeth G Wilder, Jillian H Frieder, M Alan Menter
Journal of Drugs in Dermatology : JDD|August 14, 2014
Ustekinumab treatment for psoriasis in 119 patients maintained on therapy for a minimum of one year: a reviewElizabeth G Wilder, Mahir Patel, Katherine Hebeler, et al.
Dermatology and Therapy|December 4, 2012
Emerging therapies for the treatment of psoriasisMahir Patel, Antoinette Day, Richard B Warren, et al.
JAAD Case Reports|September 3, 2020
Topical dermal steroid-induced retinopathyTaylor Hilton, Andrew DeCrescenzo, Alan Menter, et al.
Dermatologic Therapy|May 31, 2022
Cryptococcal meningitis associated with interleukin-17 inhibitor use for psoriasisJoseph Driver, Marcus Zaayman, Annika Silfvast-Kaiser, et al.
Pageof 30

Showing results (101-110 of 298) with videos related to

Sort By:
Pageof 30
Expert Opinion on Biological Therapy|March 12, 2010
The use of ustekinumab in autoimmune diseaseCaitriona Ryan, Breck Thrash, Richard B Warren, et al.
Proceedings (Baylor University. Medical Center)|December 8, 2005
Meandering linear pruritic lesionJennifer Clay Cather, J Christian Cather, M Alan Menter
Dermatology and Therapy|March 31, 2016
Erratum to: A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque PsoriasisMolly Campa, Bobbak Mansouri, Richard B Warren, et al.
International Journal of Dermatology|March 28, 2017
Prevalence of psoriasis in Brazil - a geographical surveyRicardo Romiti, Marcelo Amone, Alan Menter, et al.
Journal of Drugs in Dermatology : JDD|November 9, 2012
Impact of clobetasol propionate 0.05% spray on health-related quality of life in patients with plaque psoriasisM Alan Menter, Scott W Caveney, Ronald W Gottschalk
Cutis|March 2, 2021
Erythema Ab Igne and Malignant Transformation to Squamous Cell CarcinomaElizabeth G Wilder, Jillian H Frieder, M Alan Menter
Journal of Drugs in Dermatology : JDD|August 14, 2014
Ustekinumab treatment for psoriasis in 119 patients maintained on therapy for a minimum of one year: a reviewElizabeth G Wilder, Mahir Patel, Katherine Hebeler, et al.
Dermatology and Therapy|December 4, 2012
Emerging therapies for the treatment of psoriasisMahir Patel, Antoinette Day, Richard B Warren, et al.
JAAD Case Reports|September 3, 2020
Topical dermal steroid-induced retinopathyTaylor Hilton, Andrew DeCrescenzo, Alan Menter, et al.
Dermatologic Therapy|May 31, 2022
Cryptococcal meningitis associated with interleukin-17 inhibitor use for psoriasisJoseph Driver, Marcus Zaayman, Annika Silfvast-Kaiser, et al.
Pageof 30